Sun Pharma, L&T;: Stocks that Nilesh Jain of Anand Rathi is bullish on
Sun Pharma's counter has provided a fresh breakout after retesting its rising channel on the daily chart11-08-2020
11-08-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201507-08-2020
Hold Sun Pharmaceuticals Industries; target of Rs 575: Sharekhan
Sharekhan recommended Hold rating on Sun Pharmaceuticals Industries with a target price of Rs 575 in its research report dated July 31, 2020.07-08-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
This is to inform you that a public notice by way of an advertisement has beenpublished regarding i) Notice of the 28th Annual General Meeting of the Company for the financial year 2019-20, to be held on Thursday, August 27, 2020 by Video Conferencing/ Other Audio Visual means,, ii) E-voting and iii) Book Closure, after sending of electronic copy of the Annual Report (inter-alia containing the Notice of 28th Annual General Meeting) through email to the shareholders whose email Id were available06-08-2020
Hot Stocks | Jubilant Foodworks, Sun Pharma two buy calls for the short term
Liquidity driven rally has almost completed 78.60 percent retracement of the entire downswing seen from January 2020 top to March 2020 bottom.06-08-2020
Coronavirus treatment | Sun Pharma launches Favipiravir at Rs 35 per tablet
Favipiravir is the only oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease, the company said.04-08-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release relating to launch of FluGuard(r) (Favipiravir) in India at Rs. 35 per tablet, which we shall be releasing after sending this letter to you. This is for your information and record.04-08-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Notice Of 28Th Annual General Meeting Of The Company To Be Held On August 27, 2020, Is Enclosed Herewith Along With The Annual Report Of The Company For The Year Ended March 31, 2020.
Notice of 28th Annual General Meeting of the Company to be held on August 27, 2020, is enclosed herewith along with the Annual Report of the Company for the year ended March 31, 2020.03-08-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper advertisement published regarding i) Notice of the 28th Annual General Meeting of the Company for the financial year 2019-20, to be held on Thursday, August 27, 2020 by Video Conferencing/ Other Audio Visual means, ii) E-voting and iii) Book Closure, under Regulation 30 read with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201503-08-2020
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Reg. 34 (1) Annual Report
Submission of Annual Report of the Company for the year ended March 31, 2020 along with the Notice of the 28th Annual General Meeting of the Company.03-08-2020